| 摘要 |
An object of the present invention is to provide a method for accurately determining even a renal disease that could not have been detected by various conventional renal disease test methods with a reduced burden on a subject (a donor of a test sample). Another object of the present invention is to provide a method capable of determining an early stage renal disease, focusing on a renal disease marker substance with a small blind GFR area. Further, another object of the present invention is to provide a novel method for screening for a prophylactic/therapeutic agent for a renal disease capable of efficiently screening for a novel prophylactic/therapeutic agent for a renal disease that focused on a new, previously unnoticed renal disease marker substance. In order to achieve these objects, the present invention employs the step of detecting or quantifying one or two or more renal disease marker substances present in a test blood sample.
|
